ERIN LOTT: Open Payments
NPI 1851621056 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,146 in 71 payments from 37 companies in 2025. Trend: 2023 $1,977 · 2024 $1,638 · 2025 $2,146
Food & beverage: $1,647Long term medical supply or device loan: $499
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $600 |
| Merck Sharp & Dohme LLC | 6 | $159 |
| Kite Pharma, Inc. | 1 | $144 |
| E.R. Squibb & Sons, L.L.C. | 5 | $94 |
| PFIZER INC. | 4 | $88 |
| Lilly USA, LLC | 3 | $67 |
| ABBVIE INC. | 3 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $55 |
| Geron Corporation | 2 | $54 |
| Legend Biotech USA Inc. | 1 | $51 |
Products named: KISQALI, KEYTRUDA, Yescarta, OPDIVO, VERZENIO, RYTELO, CARVYKTI, OJJAARA.
Industry payments across SC — which companies pay providers there.
